These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 34981285)
1. Guillain-Barré syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea. Kim N; Kim JH; Park JS Neurol Sci; 2022 Mar; 43(3):1491-1493. PubMed ID: 34981285 [No Abstract] [Full Text] [Related]
7. Guillain-Barré Syndrome Following the mRNA COVID-19 Vaccination: Comment. Mungmunpuntipantip R; Wiwanitkit V Acta Neurol Taiwan; 2023 Dec; 32(4)():228-229. PubMed ID: 37781729 [TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent. Malamud E; Otallah SI; Caress JB; Lapid DJ Pediatr Neurol; 2022 Jan; 126():9-10. PubMed ID: 34717201 [No Abstract] [Full Text] [Related]
9. A case of sensory ataxic Guillain-Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer). Fukushima T; Tomita M; Ikeda S; Hattori N QJM; 2022 Jan; 115(1):25-27. PubMed ID: 34871447 [No Abstract] [Full Text] [Related]
10. Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report. Masuccio FG; Comi C; Solaro C Acta Neurol Belg; 2022 Oct; 122(5):1369-1371. PubMed ID: 34767184 [No Abstract] [Full Text] [Related]
11. What Are the Risks of Guillain-Barré Syndrome After SARS-CoV-2 Infection and COVID-19 Vaccination? Bourdette D; Silbermann E Neurology; 2023 Nov; 101(20):875-876. PubMed ID: 37852787 [No Abstract] [Full Text] [Related]
12. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine. Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR Front Immunol; 2022; 13():827306. PubMed ID: 35173736 [TBL] [Abstract][Full Text] [Related]
13. Guillain-Barre syndrome related to SARS-CoV-2 vaccinations. Finsterer J; Scorza CA; Scorza FA Clinics (Sao Paulo); 2022; 77():100113. PubMed ID: 36137343 [No Abstract] [Full Text] [Related]
15. Guillain-Barre Syndrome After Two COVID-19 Vaccinations: Two Case Reports With Follow-up Electrodiagnostic Study. Kim JW; Kim YG; Park YC; Choi S; Lee S; Min HJ; Kim MJ J Korean Med Sci; 2022 Feb; 37(7):e58. PubMed ID: 35191234 [TBL] [Abstract][Full Text] [Related]
16. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink. Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572 [TBL] [Abstract][Full Text] [Related]
18. [Guillain-Barre syndrome and thrombocytopenia after SARS-CoV-2 vaccination with Moderna. A case report]. Lázaro C; Llauradó A; Sánchez-Tejerina D; Cabirta A; Carpio C; Sotoca J; Salvadó M; Raguer N; Restrepo J; Juntas R Rev Neurol; 2022 Oct; 75(8):247-250. PubMed ID: 36218255 [TBL] [Abstract][Full Text] [Related]
19. Multifocal motor neuropathy after SARS-CoV-2 vaccination: a causal or coincidental association? Eren F; Aygul R; Tenekeci S; Ozturk S J Int Med Res; 2022 Jul; 50(7):3000605221110709. PubMed ID: 35818160 [TBL] [Abstract][Full Text] [Related]